359|438|Public
5|$|In other diseases, {{defects in}} nuclear genes lead to {{dysfunction}} of mitochondrial proteins. This {{is the case}} in Friedreich's ataxia, <b>hereditary</b> <b>spastic</b> <b>paraplegia,</b> and Wilson's disease. These diseases are inherited in a dominance relationship, as applies to most other genetic diseases. A variety of disorders can be caused by nuclear mutations of oxidative phosphorylation enzymes, such as coenzyme Q10 deficiency and Barth syndrome. Environmental influences may interact with hereditary predispositions and cause mitochondrial disease. For example, there may be a link between pesticide exposure and the later onset of Parkinson's disease. Other pathologies with etiology involving mitochondrial dysfunction include schizophrenia, bipolar disorder, dementia, Alzheimer's disease, Parkinson's disease, epilepsy, stroke, cardiovascular disease, chronic fatigue syndrome, retinitis pigmentosa, and diabetes mellitus.|$|E
5000|$|<b>Hereditary</b> <b>spastic</b> <b>{{paraplegia}}</b> (HSP, or Familial spastic paraplegia - FSP, Strümpell-Lorrain syndrome) ...|$|E
5000|$|In 2003, Kate was {{diagnosed}} with HSP (<b>Hereditary</b> <b>Spastic</b> <b>Paraplegia)</b> and is a wheelchair user.|$|E
50|$|<b>Hereditary</b> <b>spastic</b> <b>paraplegias</b> can be {{classified}} based on the symptoms; mode of inheritance; the patient’s age at onset; the affected genes; and biochemical pathways involved.|$|R
40|$|The {{endoplasmic}} reticulum is a continuous membrane system comprised of a strikingly diverse architecture. This Review addresses recent {{insights into the}} mechanisms underlying the determination of ER structure and how this varied architecture contributes to ER functional specializations, particularly in regard to <b>hereditary</b> <b>spastic</b> <b>paraplegias</b> in which ER morphology is compromised...|$|R
40|$|<b>Hereditary</b> <b>spastic</b> <b>paraplegias</b> (HSPs) are {{neurodegenerative}} {{motor neuron}} diseases characterized by progressive age-dependent loss of corticospinal motor tract function. Although the genetic basis is partly understood, {{only a fraction of}} cases can receive a genetic diagnosis, and a global view of HSP is lacking. By using whole-exome sequencing in combination with network analysis, we identified 18 previously unknown putative HSP genes and validated nearly all of these genes functionally or genetically. The pathways highlighted by these mutations link HSP to cellular transport, nucleotide metabolism, and synapse and axon development. Network analysis revealed a host of further candidate genes, of which three were mutated in our cohort. Our analysis links HSP to other neurodegenerative disorders and can facilitate gene discovery and mechanistic understanding of disease. <b>Hereditary</b> <b>spastic</b> <b>paraplegias</b> (HSPs) area group of genetically heterogeneous neu-rodegenerative disorders with prevalence between 3 and 10 per 100, 000 individuals (1). Hallmark features are axonal degeneration and progressive lower limb spasticity resulting from a loss of corticospinal tract (CST) function. HSP is classified into two broad categories, uncomplica...|$|R
5000|$|Type V {{appears to}} {{resemble}} Hereditary Spastic Paraplegia; however, {{more research is}} needed to conclude the relationship between Type V MJD and <b>hereditary</b> <b>spastic</b> <b>paraplegia.</b>|$|E
50|$|KIAA0196 (also {{known as}} strumpellin) {{is a human}} gene. The product is a protein that is a {{component}} of the WASH complex, which regulates actin assembly on intracellular vesicles. Mutations in KIAA0196 are implicated in some forms of <b>hereditary</b> <b>spastic</b> <b>paraplegia.</b>|$|E
50|$|Along with French {{neurologist}} Pierre Marie, he {{is credited}} with identifying and diagnosing an arthritic spinal deformity that was to {{become known as the}} Marie-Strümpell disease (ankylosing spondylitis). Together with French physician Maurice Lorrain, the eponymous Strümpell-Lorrain disease is named, which is an <b>hereditary</b> <b>spastic</b> <b>paraplegia.</b>|$|E
40|$|<b>Hereditary</b> <b>spastic</b> <b>paraplegias</b> are {{neurodegenerative}} disorders characterized clinically by progressive spasticity {{of the lower}} limbs. They are inherited as autosomal dominant, autosomal recessive, and X-linked traits. Four Italian families with autosomal recessive pure <b>spastic</b> <b>paraplegia</b> are reported. We show evidence of linkage to the SPG 5 locus on chromosome 8 p and our data reduce the candidate interval for SPG 5 to the 11 -cM interval spanned by D 8 S 285 and D 8 S 544. We also report the search for mutations in five genes located {{in the region and}} their exclusion as candidates for SPG 5...|$|R
40|$|An {{epidemiological}} survey of hereditary ataxias and paraplegias {{was conducted in}} Molise, a region of Italy (335, 211 inhabitants on 1 January 1989). Total prevalence was 7. 5 x 10 (- 5) inhabitants (95 % confidence limits 4. 8 - 11. 1). There were 7 patients with Friedreich's disease, 5 with early onset cerebellar ataxia with retained tendon reflexes, 4 with ataxia-telangiectasia, 9 with <b>hereditary</b> <b>spastic</b> <b>paraplegias</b> (2 autosomal dominant and 7 autosomal recessive cases). There was no patient with autosomal dominant cerebellar ataxia...|$|R
40|$|<b>Hereditary</b> <b>spastic</b> <b>paraplegias</b> (HSPs) are {{characterized}} by progressive lower extremity spasticity due to an axonal degeneration of motor and sensory neurons. We report a four-generation pedigree segregating an autosomal dominant phenotype for HSP and showing a linkage to the SPG 10 locus, coding for Kinesin family member 5 A. Subsequent to a denaturing high performance liquid chromatography (dHPLC) mutation screening we found a new missense mutation 838 C>T (R 280 C) at an invariant arginine residue in a region involved in the microtubule binding activity...|$|R
5000|$|This gene encodes {{a protein}} {{localized}} in mitochondria and {{closely related to}} paraplegin. The paraplegin gene is responsible for an autosomal recessive form of <b>hereditary</b> <b>spastic</b> <b>paraplegia.</b> This gene is a candidate gene for other hereditary spastic paraplegias or neurodegenerative disorders [...] as well as spastic ataxia-neuropathy syndrome.|$|E
5000|$|A {{mutation}} (c.947A>T) in CYP2U1 {{has been}} associated with a small number of patients with <b>Hereditary</b> <b>spastic</b> <b>paraplegia</b> in that it segregates with the disease at the homozygous state in two afflicted families. The mutation affects an amino acid (p.Asp316Val) highly conserved among CYP2U1 orthologs as well as other cytochrome P450 proteins; the p.Asp314Val mutation is located in the enzyme's functional domain, is predicted to be damaging to the enzyme's activity, and is associated with mitochondria dysfunction. [...] A second homozygous enzyme-disabling mutation has been identified in CYP2U1, c.1A>C/p.Met1?, that is associated with <1% of <b>hereditary</b> <b>spastic</b> <b>paraplegia</b> sufferers. While the role of 20-HETE in these mutations has not been established, the reduction in 20-HETE production and thereby 20-HETE's activation of the TRPV1 receptor in nerve tissues, it is hypothesized, may contribute to the disease.|$|E
50|$|Recessively-inherited {{mutations}} in NTE that substantially reduce its catalytic activity cause a rare form of <b>hereditary</b> <b>spastic</b> <b>paraplegia</b> (SPG39), in which distal parts of long spinal axons degenerate leading to limb weakness and paralysis. Organophosphate-induced delayed neuropathy a paralysing syndrome with distal degeneration of long axons results from poisoning with neuropathic organophosphorus compounds that irreversibly inhibit NTE.|$|E
40|$|<b>Hereditary</b> <b>spastic</b> <b>paraplegias</b> (HSP) are a {{heterogeneous}} group of neurodegenerative disorders leading to progressive spasticity {{of the lower}} limbs. Here, we describe clinical and genetic features in an Italian family affected by autosomal recessive HSP (ARHSP) with mental impairment and thin corpus callosum (TCC). In both affected subjects, genetic analysis revealed {{the presence of a}} homozygous small deletion (733 _ 734 delAT) leading to a frameshift (M 245 VfsX) within the coding region of SPG 11 gene, encoding spatacsin. This finding is the first independent confirmation that spatacsin loss of function mutations cause ARHPS-TCC...|$|R
40|$|SPAST {{mutations}} are {{the most}} common cause of autosomal dominant <b>hereditary</b> <b>spastic</b> <b>paraplegias</b> (AD-HSPs), but many <b>spastic</b> <b>paraplegia</b> patients are found to carry no mutations in this gene. In order to assess the contribution of ATL 1 and REEP 1 in AD-HSP, we performed mutational analysis in 27 SPAST-negative AD-HSP families. We found three novel ATL 1 mutations and one REEP 1 mutation in five index-patients. In 110 patients with sporadic adult-onset upper motor neuron syndromes, a novel REEP 1 mutation was identified in one patient. Apart from a significantly younger age at onset in ATL 1 patients and restless legs in some, the clinical phenotype of ATL 1 and REEP 1 was similar to other pure AD-HSPs. ...|$|R
40|$|Plant {{cells and}} neurons share several similarities, {{including}} non-centrosomal microtubules, motile post-Golgi organelles, separated both spatially/structurally and functionally from the Golgi apparatus {{and involved in}} vesicular endocytic recycling, as well as cell-cell adhesion domains based on the actin/myosin cytoskeleton which serve for cell-cell communication. Tip-growing plant cells such as root hairs and pollen tubes also resemble neurons extending their axons. Recently, surprising discoveries have been made {{with respect to the}} molecular basis of neurodegenerative disorders known as <b>Hereditary</b> <b>Spastic</b> <b>Paraplegias</b> and tip-growth of root hairs. All these advances are briefly discussed in the context of other similarities between plant cells and neurons...|$|R
50|$|This gene encodes {{a protein}} with several Transmembrane domains, a Rab11-binding domain and a lipid-binding FYVE finger domain. The encoded protein appears to promote Neuriteformation. A {{mutation}} in this gene {{has been reported}} to be associated with <b>Hereditary</b> <b>spastic</b> <b>paraplegia,</b> however the Pathogenicity of the mutation, which may simply represent a Polymorphism (biology), is unclear. by RefSeq, Mar 2010.|$|E
5000|$|People {{who have}} {{suffered}} cortical damage such as a stroke are capable of performing SEM. In one experiment, SEM caused stroke survivors to perform arm movements as fast as unimpaired people, despite being slower when performing the same action voluntarily. [...] Furthermore, people with pure <b>hereditary</b> <b>spastic</b> <b>paraplegia,</b> a condition effecting the corticospinal tract, are susceptible to SEM as well.|$|E
50|$|AP-5 is {{the most}} {{recently}} described complex, and one reason supporting {{the idea that it}} is an authentic adaptor complex is that it is associated with <b>hereditary</b> <b>spastic</b> <b>paraplegia,</b> as is AP-4. AP-1 is linked to MEDNIK syndrome. AP-3 is linked to Hermansky-Pudlak syndrome. COPI is linked to an autoimmune disease. COPII is linked to cranio-lenticulo-sutural dysplasia.One of the GGA proteins may be involved in Alzheimer's disease.|$|E
40|$|Background: <b>Hereditary</b> <b>spastic</b> <b>paraplegias</b> (HSPs) are characterised by {{lower limb}} {{spasticity}} due to degeneration of the corticospinal tract. We {{set out for}} an electrophysiological characterisation of motor and sensory tracts in patients with HSP. Methods: We clinically and electrophysiologically examined a cohort of 128 patients with genetically confirmed or clinically probable HSP. Motor evoked potentials (MEPs) to arms and legs, somato-sensory evoked potentials of median and tibial nerves, and nerve conduction studies of tibial, ulnar, sural, and radial nerves were assessed. Results: Whereas all patients showed clinical signs of spastic paraparesis, MEPs were normal in 27...|$|R
40|$|Background: <b>Hereditary</b> <b>spastic</b> <b>paraplegias</b> (HSPs) are a {{clinically}} and genetically heterogeneous {{group of}} neurological diseases, which typically present with progressive lower extremity weakness and spasticity causing progressive walking difficulties. Complicating neurological or extraneurological features may be present. Case Report: We describe a 19 -year-old male who was referred {{because of an}} action tremor of the hands; he later developed walking difficulties. Callosal atrophy was present on his cerebral magnetic resonance imaging scan, prompting genetic testing for SPG 11, which revealed homozygous mutations. Discussion: The clinical features, differential diagnosis and management of SPG 11, {{the most common form}} of autosomal recessive complicated HSP with a thin corpus callosum are discussed...|$|R
40|$|<b>Hereditary</b> <b>spastic</b> <b>paraplegias</b> (HSPs) are a {{group of}} single-gene {{disorders}} characterised by degeneration of the corticospinal tract axons, leading to bilateral, symmetrical, slowly-progressive spastic paraparesis, predominantly of the lower extremities. So far, âˆ¼ 30 different chromosomal HSP loci have been identified by genetic linkage analysis. Defects in intracellular trafficking and transport in myelination and abnormalities of mitochondrial proteins {{have been involved in}} HSP pathogenesis. At present, treatment of the HSPs is primarily directed symptomatically toward reducing muscle spasticity. Yet, recent progresses in the identification of HSP mutations are providing formidable tools to pharmacogenetic approaches of drug discovery, validation and prediction of individual response. Â© 2006 Informa UK Ltd...|$|R
5000|$|The {{disease was}} first {{mentioned}} in 1876 by Adolph Seeligmüller, a German neurologist, who described {{a family of}} four affected children with spasticity. Further cases were described in 1883 by Adolph Strümpell, a German neurologist. Those cases were described more extensively in 1888 by Maurice Lorrain, a French physician. [...] Due to their contribution in describing the disease, it is still named Strümpell-Lorrain disease in French speaking countries. The term <b>hereditary</b> <b>spastic</b> <b>paraplegia</b> was coined by Anita Harding in 1983.|$|E
50|$|A {{motor neuron}} disease (MND) is any of several {{neurological}} disorders that selectively affect motor neurons, the cells that control voluntary muscles of the body. They include amyotrophic lateral sclerosis (ALS), <b>hereditary</b> <b>spastic</b> <b>paraplegia</b> (HSP), primary lateral sclerosis (PLS), progressive muscular atrophy (PMA), progressive bulbar palsy (PBP) and pseudobulbar palsy. Spinal muscular atrophies (SMA) are sometimes included in the group by some neurologists but it is different disease with clear genetic cause. They are neurodegenerative in nature and cause increasing disability and eventually, death.|$|E
50|$|Emma Doyle {{has spent}} her life {{exceeding}} expectations. She {{was born with}} a rare condition called <b>Hereditary</b> <b>spastic</b> <b>paraplegia</b> which is similar to cerebral palsy. Her family and friends explain how Emma was told she would never walk but now uses just a crutch to get around. She has a fear of water but has learned to swim and now wants to attempt something even more difficult - waterskiing. Emma shares her hopes with us and says that she wants to discover her own limitations, not have them set for her by others. She visits IASC, a manmade lake built by World disabled Waterski Champion Eamonn Prunty.|$|E
40|$|The <b>hereditary</b> <b>spastic</b> <b>paraplegias</b> (HSPs) are a genet-ically {{heterogeneous}} {{group of}} disorders characterised by progressive corticospinal tract degeneration {{and the development}} of lower limb spasticity [1, 2]. Autoso-mal-dominant HSP is the most commonly inherited form of the disease and in this group, SPG 4 mutations account for * 40 % of cases [1]. The SPG 4 gene codes for spastin, a critical neuronal protein that maintains organelle axonal transport by severing and rearranging the microtubule network [3, 4]. Dysfunctional mutant proteins or insufficient quantities of the wild-type protein inhibit this dynamic shuttling process resulting in axonal swelling and progressive retrograde degen-eration that preferentially affects the long corticospinal axons [3, 4]...|$|R
40|$|Paraplegin is an m-AAA {{protease}} of the mitochondrial inner membrane that {{is linked}} to <b>hereditary</b> <b>spastic</b> <b>paraplegias.</b> The gene encodes an FtsH-homology protease domain in tandem with an AAA+ homology ATPase domain. The protein is believed to form a hexamer that uses ATPase-driven conformational changes in its AAA-domain to deliver substrate peptides to its protease domain. We present the crystal structure of the AAA-domain of human paraplegin bound to ADP at 2. 2 Å. This enables assignment of the roles of specific side chains within the catalytic cycle, and provides the structural basis for understanding the mechanism of disease mutations. Enhanced version: This article can also {{be viewed as an}} enhanced versio...|$|R
40|$|Small-diameter myelinated CNS axons are {{preferentially}} {{affected in}} multiple sclerosis (MS) {{and in the}} <b>hereditary</b> <b>spastic</b> <b>paraplegias</b> (HSP), in which the distal axon degenerates. Mitochondrial dysfunction has been implicated in the pathogenesis {{of these and other}} disorders involving axonal degeneration. The aim {{of this study was to}} determine whether the frequency of axonal mitochondria changes along the length of small-diameter fibers and whether there is a preferential localization to the region of the node of Ranvier. We find that mitochondrial numbers do not change along the length of a myelinated small-diameter fiber, and, in contrast to the peripheral nervous system, there is no tendency for mitochondrial numbers to increase at the node...|$|R
50|$|In other diseases, {{defects in}} nuclear genes lead to {{dysfunction}} of mitochondrial proteins. This {{is the case}} in Friedreich's ataxia, <b>hereditary</b> <b>spastic</b> <b>paraplegia,</b> and Wilson's disease. These diseases are inherited in a dominance relationship, as applies to most other genetic diseases. A variety of disorders can be caused by nuclear mutations of oxidative phosphorylation enzymes, such as coenzyme Q10 deficiency and Barth syndrome. Environmental influences may interact with hereditary predispositions and cause mitochondrial disease. For example, there may be a link between pesticide exposure and the later onset of Parkinson's disease. Other pathologies with etiology involving mitochondrial dysfunction include schizophrenia, bipolar disorder, dementia, Alzheimer's disease, Parkinson's disease, epilepsy, stroke, cardiovascular disease, chronic fatigue syndrome, retinitis pigmentosa, and diabetes mellitus.|$|E
5000|$|Worldwide, the {{prevalence}} of all hereditary spastic paraplegias combined {{is estimated to be}} 2 to 6 in 100,000 people. A Norwegian study of more than 2.5 million people published in March 2009 has found an HSP prevalence rate of 7.4/100,000 of population - a higher rate, but in the same range as previous studies. No differences in rate relating to gender were found, and average age at onset was 24 years. In the United States, <b>Hereditary</b> <b>Spastic</b> <b>Paraplegia</b> is listed as a [...] "rare disease" [...] by the Office of Rare Diseases (ORD) of the National Institutes of Health which means that the disorder affects less than 200,000 people in the US population.|$|E
5000|$|There {{are a few}} {{clinical}} {{situations in}} which it is likely that someone may not be a candidates for the surgery. These situations include those who have suffered meningitis, a congenital (birth-originating) brain infection, congenital hydrocephalus unrelated to the person's premature birth, a person who has suffered head trauma, or a person with some sort of familial disease (e.g., those with <b>hereditary</b> <b>spastic</b> <b>paraplegia</b> are said to not be SDR candidates). Also precluded are people who have a [...] "mixed" [...] CP with predominant rigidity or dystonia, significant athetosis, or ataxia; and those who have very severe scoliosis. However, as with any procedure, an individual evaluation is needed in all instances to determine eligibility.|$|E
40|$|Full list {{of author}} {{information}} {{is available at the}} end of the articleBackground High-throughput sequence capture methods and next generation sequencing (NGS) technologies make exome sequencing an effective method to identify the cause of Mendelian disorders [1 - 3]. Exome sequencing has primar-ily been applied to identify novel genetic causes of disease although it is increasingly being used in the diagnostic setting, particular in disorders displaying locus heterogen-eity such as ataxias, Charcot-Marie-Tooth disease (CMT), <b>hereditary</b> <b>spastic</b> <b>paraplegias</b> (HSP) and retinitis pigmen-tosa [3 - 5]. Large genes containing numerous mutations may also be effectively screened by NGS. In addition, exo-me sequencing may be an important tool for correctly diagnosing rare disorders, [6] particularly when they ma-nifest phenotypic heterogeneity...|$|R
40|$|The <b>hereditary</b> <b>spastic</b> <b>paraplegias</b> (HSP) are {{characterized}} by spastic gait with weakness in the legs and additional neurological or extra-neurological signs in "complicated" forms. The past two decades have witnessed major advances {{in our understanding of}} their molecular bases with the identification of a plethora of loci and the cloning of several SPG genes. Combined genetic and clinical information has permitted a modern, molecularly-driven classification and an improved diagnosis, with several new data on the possible disease mechanisms. Further heterogeneity will rapidly emerge with the diffusion of next-generation sequencing platforms and, under the shadow of common themes in the pathogenesis, new therapeutic options will likely emerge for a great number of patients...|$|R
40|$|The <b>hereditary</b> <b>spastic</b> <b>paraplegias</b> (HSPs) {{are genetically}} {{heterogeneous}} disorders characterized by progressive lower-extremity weakness and spasticity. The molecular pathogenesis is poorly understood. We report {{discovery of a}} dominant negative mutation in the NIPA 1 gene in a kindred with autosomal dominant HSP (ADHSP), linked to chromosome 15 q 11 -q 13 (SPG 6 locus); and precisely the same mutation in an unrelated kindred with ADHSP that was too small for meaningful linkage analysis. NIPA 1 is highly expressed in neuronal tissues and encodes a putative membrane transporter or receptor. Identification of the NIPA 1 function and ligand will aid an understanding of axonal neurodegeneration in HSP and may have important therapeutic implications...|$|R
